News
- Author:
- Susan London
Publish date: January 30, 2019
SAN FRANCISCO – In the phase 3 TAGS trial, the gastrectomy subgroup did have higher rates of grade 3 or 4 adverse events.
News
- Author:
- Susan London
Publish date: January 29, 2019
SAN FRANCISCO – Tecemotide did not improve recurrence-free or overall survival relative to placebo when given after R0/R1 resection of liver-only C...
News
- Author:
- Susan London
Publish date: January 24, 2019
SAN FRANCISCO – Patients with BRAF V600E–mutated biliary tract cancer in a basket trial had a response rate of 42% when given the combination of da...
News
- Author:
- Susan London
Publish date: January 24, 2019
SAN FRANCISCO – Among patients with untreated HCC given first-line kinase inhibitors, those having a response based on mRECIST criteria lived twice...
News
- Author:
- Susan London
Publish date: January 23, 2019
SAN FRANCISCO – In KEYNOTE-181, second-line pembrolizumab reduced risk of death by 31% relative to chemotherapy among patients whose esophageal and...
News
- Author:
- Susan London
Publish date: January 22, 2019
SAN FRANCISCO – Older adults appeared to derive both progression-free and overall survival benefit in the GAMMA-1 trial, which tested addition of a...
News
- Author:
- Susan London
Publish date: January 22, 2019
SAN FRANCISCO – Adding adjuvant oxaliplatin HIPEC to routine adjuvant systemic chemotherapy did not improve survival without peritoneal recurrence ...
News
- Author:
- Susan London
Publish date: December 28, 2018
SAN ANTONIO – Although neoadjuvant chemotherapy doubled the proportion of women eligible for breast-conserving surgery, about 40% chose mastectomy ...
News
- Author:
- Susan London
Publish date: December 27, 2018
SAN ANTONIO – Overall survival is better in breast cancer patients aged 65 years and older who receive adjuvant chemotherapy, although patients giv...
News
- Author:
- Susan London
Publish date: December 18, 2018
SAN ANTONIO – A cohort study of 560 breast cancer survivors aged 40 or younger at diagnosis finds that breast satisfaction and several domains of q...
News
- Author:
- Susan London
Publish date: December 14, 2018
SAN ANTONIO - Oxybutynin reduced hot flash scores by at least two-thirds, improved measures of quality of life, and was safe and well tolerated in ...
News
- Author:
- Susan London
Publish date: December 12, 2018
SAN ANTONIO – A phase 3 trial among women who had undergone lumpectomy could not refute the hypothesis that PBI was inferior to WBI, but the absolu...
News
- Author:
- Susan London
Publish date: December 11, 2018
SAN ANTONIO – In patients with a positive sentinel node, axillary radiation has similar efficacy to axillary lymph node dissection and less morbidi...
Video
- Author:
- Susan London
Publish date: December 7, 2018
SAN ANTONIO – The 6-week reduction in a hot flash score capturing both frequency and severity was about 30% with placebo, 65% with oxybutynin 2.5 m...
Video
- Author:
- Susan London
Publish date: December 7, 2018
SAN ANTONIO – Younger breast cancer patients who undergo unilateral or bilateral mastectomy report lower breast satisfaction and poorer psychosocia...
